Mechanisms of Cellular Immunity in the Female Reproductive Tract (R01) | Apply Online

Opportunity Summary:

The National Institutes of Health released this R01 Funding Opportunity Announcement (RFA-AI-12-054), titled "Mechanisms of Cellular Immunity in the Female Reproductive Tract (R01)," to drive basic research on how effective, antigen-specific memory T cell responses are generated, maintained, and function within the female reproductive tract (FRT). The central scientific focus is on uncovering the mechanisms that produce durable, protective T cell immunity at this mucosal site, with an eye toward building the foundational knowledge needed for future vaccines that can prevent infection by HIV and other viral pathogens that enter through or replicate in the FRT. The emphasis is explicitly on discovery and mechanistic immunology rather than product development, meaning the FOA is not meant to fund preclinical or clinical testing of vaccine candidates or adjuvants, but instead the kind of fundamental work that makes rational vaccine design possible later on.

A key message in the announcement is the need to understand what "effective" memory T cell immunity looks like in the FRT and what biological rules govern it. In practice, this points to research questions such as how tissue-resident memory T cells and circulating memory populations are established in different compartments of the reproductive tract, how antigen exposure and local inflammation shape the quality and durability of memory, and how local tissue factors influence T cell trafficking, retention, survival, and effector function. Because the FRT has distinctive immunological constraints and features compared with blood or other mucosal tissues, the FOA is essentially inviting applicants to explain what is unique about immune memory in this environment and how those unique features can be leveraged to create protective immunity rather than short-lived or poorly targeted responses.

The public health driver behind the FOA is vaccine-relevant knowledge for HIV, while still leaving room for broader applicability to other viral infections affecting the FRT. The announcement frames the FRT as a critical site where localized immune defenses can determine susceptibility and early control of infection, so the ability to elicit robust and durable T cell responses there is treated as a major unmet need. Importantly, NIH signals that it wants innovative basic science that clarifies mechanisms, which often includes dissecting cellular pathways, local tissue cues, and immunological circuitry that collectively determine whether antigen-specific memory T cells can persist and respond rapidly when a pathogen is encountered again.

NIH also notes that a related concept previously appeared as PA-12-104, and it urges applicants to read this FOA carefully because differences could affect whether an application is considered responsive. That is a practical instruction: investigators should not assume that a proposal prepared for the earlier opportunity will automatically fit this one without adjustment, because review expectations, scope, or required elements may have changed. Another notable feature is the explicit encouragement for investigators who have the right expertise but are not currently working in the HIV field to apply, which suggests NIH was trying to bring in fresh perspectives from mucosal immunology, reproductive biology, virology, tissue immunology, or T cell biology more broadly.

From an administrative standpoint, this is a discretionary grant mechanism using the NIH R01 funding instrument under health-related activity categories associated with allergy, infectious diseases, and microbiology (CFDA 93.855 and 93.856). The FOA lists an estimated total funding amount of $2,000,000. Cost sharing or matching is not required, which is typical for NIH research project grants and lowers barriers for a wide range of institutions.

Eligibility is broad and includes many types of domestic and non-domestic applicants. Eligible applicants span state, county, city or township governments and special district governments, public and private institutions of higher education, nonprofit organizations with or without 501(c)(3) status, for-profit organizations (including small businesses), independent school districts, and various tribal governments and tribal organizations. The FOA also makes clear that foreign organizations and foreign institutions may apply, that non-U.S. components of U.S. organizations are eligible, and that foreign components as defined by NIH policy are allowed. It additionally highlights inclusion of organizations such as Historically Black Colleges and Universities (HBCUs), Tribal Colleges and Universities (TCCUs), Hispanic-serving institutions, Alaska Native and Native Hawaiian-serving institutions, and Asian American Native American Pacific Islander-serving institutions (AANAPISIs), reflecting NIH's standard effort to broaden participation across institution types.

Timing details in the source data indicate the FOA was posted and created on March 7, 2013, with an original and current closing date of July 24, 2013, and an archive date of August 24, 2013. In other words, this particular opportunity is historical rather than currently open, but it is still useful as a snapshot of NIH priorities and the kind of mechanistic FRT cellular immunity research NIH has sought to stimulate. The full announcement was linked through the NIH grants guide, and NIH provided general contact routes through the NIH Office of Extramural Research webmaster for access or technical issues with the posting.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: Mechanism for Time Sensitive Research Opportunities in Environmental Health Sciences (R21)

Previous opportunity: FY13 SNAP Program and Technology Improvement Grants

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA AI 12 054

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (RFA AI 12 054) also looked into and applied for these:

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA AI 12 054", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.